Adma Biologics PE ratio ADMA

Share price divided by earnings per share over the last twelve months, since 2024.

Today, Oct 23, 2026: 15.3×
2-year median: 21.5×
Against its 2-year history: 20th; percentile: 0 is its lowest day, 100 its highest
2-year range: 11.7× to 145×
Peer median: 37.5×

Adma Biologics' PE ratio is 15.3× as of Oct 23, 2026: a share price of $10.68 against $0.70 of earnings per share over the last twelve months.

That is below its 2-year median of 21.5×, lower than on 80% of days in the last 2 years.

Over that time it ranged from 11.7× in Jun 2026 to 145× in Oct 2024.

The median for 9 biotech stocks of a similar size is 37.5×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	15.3×	11.7×	25.9×
2025	22.7×	16.9×	66.3×
2024	62.3×	62.1×	145×

Against its peers

Companies in Biotechnology nearest Adma Biologics' size, closest first, today.

Company	PE ratio
ADMAAdma Biologics	15.3×
VCELVericel	92.5×
MGTXMeiraGTx	13.0×
KRYSKrystal Biotech	39.0×
RGENRepligen	242×
TECHBIO-TECHNE	63.1×
HALOHalozyme Therapeutics	37.5×
NBIXNeurocrine Biosciences	20.9×
EXELExelixis	20.3×
INCYIncyte	14.7×
Peer median	37.5×

Where Adma Biologics ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Adma Biologics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.